ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and equity investments in commercial real estate property in the United States. The company invests in commercial real estate credit investments, including floating-rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine financing, preferred equity investments, and CRE equity investments. It qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Exantas Capital Corp. and changed its name to ACRES Commercial Realty Corp. in February 2021. ACRES Commercial Realty Corp. was incorporated in 2005 and is based in Uniondale, New York.

ACRES Commercial Realty Corp.

KWG Resources ( ($TSE:CACR) ) has issued an update. The Canadian Chrome Company Inc. has scheduled its annual and special shareholder meeting for J...

Canadian Chrome Company Sets June Shareholder Meeting and Extends Key Warrants

In a report released today, Jarrod Castle from UBS maintained a Buy rating on Accor SA, with a price target of €63.00. According to TipRanks, Castl...

UBS Reaffirms Their Buy Rating on Accor SA (0H59)

Kepler Capital analyst Julien Richer maintained a Buy rating on Accor SA on April 2 and set a price target of €52.00. The company’s shares closed l...

Kepler Capital  Remains a Buy on Accor SA (0H59)

Drumz ( ($GB:ACRM) ) has issued an announcement. Acuity RM Group has issued 2,201,408 new ordinary shares to certain directors and a PDMR in lieu o...

Acuity RM issues new shares for deferred salaries and supplier payments

Jefferies analyst maintained a Buy rating on Acrivon Therapeutics, Inc. on March 20 and set a price target of $14.00. The company’s shares closed l...

Jefferies Keeps Their Buy Rating on Acrivon Therapeutics, Inc. (ACRV)

In a report released on March 20, Julien Richer from Kepler Capital maintained a Buy rating on Accor SA, with a price target of €52.00. The company...

Kepler Capital  Keeps Their Buy Rating on Accor SA (0H59)

An update from Acrivon Therapeutics, Inc. ( ($ACRV) ) is now available. On March 19, 2026, Acrivon Therapeutics reported fourth quarter and full-ye...

Acrivon Highlights Positive ACR-368 Data and 2025 Results

KWG Resources ( ($TSE:CACR) ) has issued an update. The Canadian Chrome Company Inc. has launched a proposed private placement of up to 10,714,285 ...

Canadian Chrome Company Plans $15 Million Private Placement to Fund Exploration

Ares Commercial ( ($ACRE) ) has issued an announcement. On March 10, 2026, ACRC Lender LLC, a subsidiary of Ares Commercial Real Estate Corporation...

Ares Commercial Extends Secured Revolving Credit Facility

American Clean Resources Group ( ($ACRG) ) has provided an update. American Clean Resources Group, Inc. disclosed that on March 11, 2026, it entere...

American Clean Resources Signs Services Agreement With SMS

Acrux ( ($AU:ACR) ) just unveiled an announcement. Acrux Limited has secured a second advance of $0.55 million against its FY26 R&D Tax Incentive f...

Acrux Secures $0.55m Advance on FY26 R&D Tax Incentive to Support HRT Development

Aclaris Therapeutics ( ($ACRS) ) has provided an announcement. From March 2 to March 9, 2026, Aclaris Therapeutics, Inc. sold 12.7 million shares o...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ACR	$19.23	+0.89%	8.62K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ACR	$19.23	+0.9%	8.62K
3
4
5
6

ACR

ACR

No Data Available

Get ACRES Commercial Realty Corp. Data in Excel

Get ACRES Commercial Realty Corp. Data in Excel